Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With a Single Brain Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03004820
What this trial is testing

Prevention of Ischemic Conditions in Non-disabling Stroke/Transient Ischemic Attack With Remote Ischemic Conditioning

Who this might be right for
Transient Ischemic AttackNon-disabling Stroke
Capital Medical University 167
Testing effectiveness (Phase 2)Looking for participantsNCT06401824
What this trial is testing

Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases

Who this might be right for
NSCLC Stage IVBrain Metastases, Adult
Maastricht University Medical Center 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06483672
What this trial is testing

Furmonertinib Combined With Anlotinib in Lung Adenocarcinoma Patients With EGFR Mutations and Brain Metastases

Who this might be right for
Adenocarcinoma of Lung Metastatic to Brain
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 27
Not applicableEnded earlyNCT01821443
What this trial is testing

A Single Arm Study of Neurocognitive Outcomes in Patients With Brain Metastases Managed With Stereotactic Radiosurgery (SRS)

Who this might be right for
Brain Metastases
University of California, San Francisco 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07539753
What this trial is testing

Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases

Who this might be right for
Breast CancerBrain MetastasesHR+/HER2- Breast Cancer
Nanfang Hospital, Southern Medical University 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT05593094
What this trial is testing

Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsHER2-positive Breast Cancer
Hoffmann-La Roche 210
Testing effectiveness (Phase 2)UnknownNCT04415320
What this trial is testing

X-396 (Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases

Who this might be right for
Lung Cancer, Nonsmall CellBrain Metastases
Betta Pharmaceuticals Co., Ltd. 37
Testing effectiveness (Phase 2)Study completedNCT01480583
What this trial is testing

GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases

Who this might be right for
Breast CancerBrain Metastases
Angiochem Inc 85
Testing effectiveness (Phase 2)Looking for participantsNCT06016387
What this trial is testing

Tucatinib, Trastuzumab and Capecitabine With Brain and/or Spinal Radiotherapy (XRT) in Patients With HER2+, HER2 Mutated and/or HER2-amplified Metastatic Breast Cancer and Leptomeningeal Disease: A Multi-centre Phase II, Single Arm Feasibility Study

Who this might be right for
HER2-positive Breast CancerLMD
Sunnybrook Health Sciences Centre 30
Large-scale testing (Phase 3)UnknownNCT00268684
What this trial is testing

Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell LungNeoplasm Metastasis
Tel-Aviv Sourasky Medical Center 381
Testing effectiveness (Phase 2)UnknownNCT04158947
What this trial is testing

HER2+ Breast Cancer Patients With Active Brain Metastases Treated With Afatinib & T-DM1 vs. T-DM1 Alone

Who this might be right for
HER2-positive Breast CancerBrain Metastases
xuexin he 130
Not applicableActive Not RecruitingNCT03391362
What this trial is testing

Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases

Who this might be right for
Brain MetastasesSmall Cell Lung Cancer
Brigham and Women's Hospital 100
Large-scale testing (Phase 3)Study completedNCT00390806
What this trial is testing

Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 472
Not applicableStudy completedNCT01536990
What this trial is testing

Sensitivity to Change of the Lower Extremity Functional Scale in Patients With Stroke

Who this might be right for
Lower Extremity DysfunctionStroke
Mayo Clinic 39
Early research (Phase 1)Study completedNCT00003020
What this trial is testing

LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 24
Not applicableUnknownNCT05477316
What this trial is testing

Assess the Efficacy of Cerebellar IMRT Combined With Cerebral SRS in Patients With Brain Metastases

Who this might be right for
Brain MetastasesPosterior Fossa LesionCerebral Lesion
Hadassah Medical Organization 37
Not applicableStudy completedNCT02886572
What this trial is testing

SIMT Stereotactic Radiosurgery Outcomes Study

Who this might be right for
Brain Metastases, Adult
Duke University 40
Testing effectiveness (Phase 2)UnknownNCT03691051
What this trial is testing

Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer

Who this might be right for
HER2 Positive Metastatic Breast Cancer
Henan Cancer Hospital 78
Testing effectiveness (Phase 2)UnknownNCT04978753
What this trial is testing

The Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung CancerBrain Metastases
Li-kun Chen 54
Testing effectiveness (Phase 2)UnknownNCT04643847
What this trial is testing

A Phase II Trial of Upfront Radiotherapy Plus Almonertinib for Epidermal Growth Factor Receptor(EGFR)-Mutant Non-small-cell Lung Cancer(NSCLC) Patients With Brain Metastases

Who this might be right for
EGFR Positive Non-small Cell Lung CancerBrain Metastases
First People's Hospital of Hangzhou 47
Next Page